What a Closed Loop System for Insulin Delivery Contains: Breaking Down Artificial Pancreas Technology in 2026

What a Closed Loop System for Insulin Delivery Contains: Breaking Down Artificial Pancreas Technology in 2026 Review Key Takeaways Closed-loop insulin delivery systems represent a revolutionary advancement in diabetes management, combining three essential components to automate blood sugar control and significantly improve patient outcomes.

The Vitamin D Debate: From Universal Supplement to Precision Therapy

The Vitamin D Debate: From Universal Supplement to Precision Therapy Review Abstract Vitamin D supplementation has evolved from a simple solution to rickets into one of medicine’s most debated therapeutic interventions. This paper examines the current evidence surrounding vitamin D’s role in health and disease,

Managing Diabetes in the Age of Continuous Glucose Monitoring (CGM): How Practice is Changing

Managing Diabetes in the Age of Continuous Glucose Monitoring (CGM) How Practice is Changing Review Abstract The integration of continuous glucose monitoring technology into diabetes management has significantly reshaped clinical practice over the past decade. Continuous glucose monitoring systems provide real time, dynamic assessment of interstitial glucose

From NAFLD to MASLD: Does the New Nomenclature Actually Change Care?

From NAFLD to MASLD Does the New Nomenclature Actually Change Care Review Abstract The transition from non alcoholic fatty liver disease to metabolic dysfunction associated steatotic liver disease represents a significant conceptual evolution in hepatology rather than a purely semantic change. Endorsed by major international

Type 2 Diabetes Mellitus: Cellular Mechanisms, Reductionist Pitfalls, and Evidence-Based Prevention

Type 2 Diabetes Mellitus as a Multifactorial Cardiometabolic Disease: Cellular Mechanisms, Reductionist Pitfalls, and Evidence-Based Prevention Narrative Review Abstract Type 2 diabetes mellitus (T2DM) is a progressive, heterogeneous, multi-organ metabolic disease characterized by chronic hyperglycemia arising from inadequate insulin secretion relative to metabolic demand, usually

Microplastics in Coffee Pods: Current Evidence and Potential Health Implications

Microplastics in Coffee Pods: Current Evidence and Potential Health Implications Key Takeaways Research reveals alarming levels of microplastic contamination in single-use coffee pods, with significant health implications for daily coffee drinkers and actionable solutions available. • A single plastic coffee pod can release over

The Microbiome and Metabolism: Can Gut Flora Be the Next Endocrine Organ?

The Microbiome and Metabolism: Can Gut Flora Be the Next Endocrine Organ?   Abstract The human gut microbiome has increasingly been recognized as a central determinant of metabolic health, with growing evidence suggesting that it functions not merely as a collection of commensal microorganisms but as a

Obesity as Chronic Disease: Building a Follow-up Model Like HTN/A1c

Obesity as Chronic Disease Building a Follow-up Model Like HTNA1c   Abstract Obesity is increasingly recognized as a chronic, relapsing, multifactorial disease that requires long term clinical management rather than episodic intervention. Its pathophysiology involves complex interactions among genetic predisposition, neuroendocrine regulation, metabolic adaptation, environmental

Thyroid Cancer Overdiagnosis: When Screening Causes More Harm Than Good

Thyroid Cancer Overdiagnosis When Screening Causes More Harm Than Good  Abstract The incidence of thyroid cancer has risen substantially over the past three decades, drawing increased attention from clinicians, researchers, and public health authorities. Much of this rise has been attributed not to a true surge in aggressive

Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs

Why GLP-1 Receptor Agonists Are Becoming Essential Cardiovascular Drugs Introduction Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a transformative class of medications in the management of type 2 diabetes, demonstrating an approximate 14 percent reduction in major adverse cardiovascular events. Initially developed

What a Closed Loop System for Insulin Delivery Contains: Breaking Down Artificial Pancreas Technology in 2026